(Adnkronos) - “Da 12 anni anche in Italia, Leo Pharma è un’azienda con 108 anni di storia spesi nell’area delle patologie dermatologiche. E vogliamo essere il partner di riferimento per i dermatologi. Lo siamo stati nel passato, lo siamo attualmente e vogliano esserlo nel futuro”.
Category
🗞
NewsTranscript
00:00What is the role of the hand eczema?
00:04The chronic hand eczema, depending on the severity,
00:07how serious it is, let's say in clinical form,
00:10it is important the hands themselves,
00:12well, prevents the correct functioning.
00:15It is an invalidating pathology, not only from a clinical point of view,
00:19but also for the psychological impact it can have.
00:22The research and, of course, the partnership with other companies
00:25has led to the solution, which we will put on the market in a fairly short time,
00:30of a therapeutic solution that will be innovative
00:33and will try to satisfy that need that is still so unsatisfied in hand eczema.
00:38Why all the dermatology?
00:40Because the organ referred to is the skin,
00:43the skin is clearly a visible organ,
00:45so the life, not only professional,
00:48but of strongly impacted relationship in pathologies
00:51that clearly impact this organ.
00:53So any deviation from what is a healthy skin
00:57involves social, clinical impacts,
01:00and also, why not, expensive in terms of expenses.
01:03Leofarma has always been committed to dermatology.
01:06Leofarma is a fairly young company in our country,
01:10about 12 years ago we established Leofarma Italia,
01:13a company with 108 years of history,
01:15108 years spent in this area of medicine,
01:18which are dermatological pathologies.
01:21We talked about chronic hand eczema,
01:24but there are others, we are committed to psoriasis,
01:26to atopic dermatitis,
01:28and we are always looking for solutions that can be innovative solutions,
01:31so first of all a new class of drugs,
01:34or solutions that can satisfy needs that still do not have,
01:39in the medical therapeutic framework, optimal solutions.
01:43As I said, we are also pushing to look for partnerships,
01:46to go and look for solutions in rare diseases,
01:49and we want to be the benchmark for dermatologists.
01:53We have been in the past, we are in the present,
01:56we will be in the future.
01:58So a benchmark company for this specialty.